CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER

This adverse event was reported 910 times

These drugs are most commonly taken by patients reporting CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 686
1 ESOMEPRAZOLE MAGNESIUM 670
2 ESOMEPRAZOLE SODIUM 616
3 LANSOPRAZOLE 496
4 LISINOPRIL 340
5 FUROSEMIDE 333
6 PANTOPRAZOLE SODIUM 325
7 ASPIRIN 305
8 ASPIRIN 325 MG 298
9 ASPIRIN 81 MG 298
See all common drugs associated with CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER

CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLOROXYLENOL 0.3% 2 0.0667
1 BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE 1 0.0417
2 GLYCOLIC ACID 1 0.0400
3 CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE 5 0.0160
4 CROFELEMER 1 0.0152
5 DOXERCALCIFEROL 20 0.0147
6 CALCIUM ACETATE CAPSULES 667 MG 57 0.0132
7 CEFPROZIL 7 0.0119
8 SORBITOL 6 0.0119
9 AMISH ORIGINS MEDICATED 6 0.0111
See all drugs enriched for association with CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER

CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 45 0.0107
1 alpha-Hydroxy Acid [EPC] 9 0.0079
2 Vitamin D3 Analog [EPC] 122 0.0066
3 Non-narcotic Antitussive [EPC] 62 0.0061
4 Cephalosporin Antibacterial [EPC] 34 0.0056
5 Antidiarrheal [EPC] 1 0.0054
6 RNA Synthetase Inhibitor Antibacterial [EPC] 40 0.0051
7 Antihypoglycemic Agent [EPC] 12 0.0047
8 gamma-Aminobutyric Acid A Receptor Agonist [EPC] 4 0.0033
9 Central alpha-2 Adrenergic Agonist [EPC] 139 0.0031
See all drug classes enriched for association with CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER